Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Comparison of Tc-99m Sestamibi and F-18 FDG-PET in the Assessment of Multiple Myeloma

GUANG-UEI HUNG, CHIEN-CHUNG TSAI, SHIH-CHUAN TSAI and WAN-YU LIN
Anticancer Research November 2005, 25 (6C) 4737-4741;
GUANG-UEI HUNG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIEN-CHUNG TSAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIH-CHUAN TSAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WAN-YU LIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wylin@vghtc.vghtc.gov.tw
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 25 no. 6C 4737-4741
PubMed 
16334169

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received July 4, 2005
  • Accepted August 31, 2005
  • Published online November 1, 2005.

Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. GUANG-UEI HUNG1,
  2. CHIEN-CHUNG TSAI2,
  3. SHIH-CHUAN TSAI3 and
  4. WAN-YU LIN4
  1. 1Department of Nuclear Medicine, Changhua Christian Hospital, Changhua
  2. 2Department of Radiology, Tainan Municipal Hospital, Tainan
  3. 3Medicine, Show Chwan Memorial Hospital, Changhua
  4. 4Department of Nuclear Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
  1. Correspondence to: Wan-Yu Lin, MD, Department of Nuclear Medicine, Taichung Veterans General Hospital, 160, Taichung Harbor Road, Section 3, Taichung 407, Taiwan. Tel: (886)4-23741349, Fax: (886)4-23741348, e-mail: wylin{at}vghtc.vghtc.gov.tw

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 25 (6C)
Anticancer Research
Vol. 25, Issue 6C
1 Nov 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of Tc-99m Sestamibi and F-18 FDG-PET in the Assessment of Multiple Myeloma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Comparison of Tc-99m Sestamibi and F-18 FDG-PET in the Assessment of Multiple Myeloma
GUANG-UEI HUNG, CHIEN-CHUNG TSAI, SHIH-CHUAN TSAI, WAN-YU LIN
Anticancer Research Nov 2005, 25 (6C) 4737-4741;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Comparison of Tc-99m Sestamibi and F-18 FDG-PET in the Assessment of Multiple Myeloma
GUANG-UEI HUNG, CHIEN-CHUNG TSAI, SHIH-CHUAN TSAI, WAN-YU LIN
Anticancer Research Nov 2005, 25 (6C) 4737-4741;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 18F-FDG PET/CT, 99mTc-MIBI, and MRI in Evaluation of Patients with Multiple Myeloma
  • Google Scholar

More in this TOC Section

  • Role of Stromal CD25+/CD8+ Lymphocyte Ratio in Patients With Grade 2-3 Cervical Intraepithelial Neoplasia (CIN 2-3): A Retrospective Single-center Study
  • Immune Checkpoint Inhibitor-induced Uveitis: Disproportionality and Timing Analyses of the Japanese Pharmacovigilance Database
  • The Impact of State-trait Anxiety Inventory (STAI) Self-evaluation versus 25-year Outcome: A Prospective Follow-up Study in Patients With Breast Cancer Symptoms
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire